Number of concomitant drugs with thrombocytopenic adverse effects and the extent inflammatory response resolution are risk factors for thrombocytopenia in patients treated with linezolid for more than 14 days

Prolonged treatment with linezolid (LZD) is known to cause thrombocytopenia. However, some patients do not develop thrombocytopenia despite long-term administration of LZD. To determine the risk factors for LZD-associated thrombocytopenia in patients undergoing long-term LZD therapy, we conducted a...

Descripción completa

Detalles Bibliográficos
Autores principales: Sato, Yoshitaka, Iguchi, Mitsutaka, Kato, Yoshiaki, Morioka, Hiroshi, Hirabayashi, Aki, Tetsuka, Nobuyuki, Tomita, Yuka, Kato, Daizo, Yamada, Kiyofumi, Kimura, Hiroshi, Yagi, Tetsuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nagoya University 2020
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7548242/
https://www.ncbi.nlm.nih.gov/pubmed/33132425
http://dx.doi.org/10.18999/nagjms.82.3.407

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7548242/
https://www.ncbi.nlm.nih.gov/pubmed/33132425
http://dx.doi.org/10.18999/nagjms.82.3.407

Ejemplares similares